Sterlite Electric Limited (formerly Sterlite Power)Unlisted Shares
₹ 498▲2.05%(10.00)
About the company
Sterlite Electric Limited (formerly Sterlite Power) is a leading global developer of power transmission infrastructure, with projects of over ~12,500 circuit km and 22,719 MVA in India and Brazil.
With an industry-leading portfolio of power conductors, EHV cables, and OPGW, Sterlite Power also offers solutions for upgrading, uprating, and strengthening existing networks. The company has set new benchmarks in the industry through the use of cutting-edge technologies and innovative financing. Sterlite Power is also the sponsor of IndiGrid, India's first power sector Infrastructure Investment Trust (InvIT), listed on the BSE and NSE.
Highlights of FY18-19
a) Total consolidated income – ₹3,571 Cr.
b) Total Circuit Kilometers – 12,500
c) Total availability of assets (transmission lines) – 99.84%
Fundamentals
Valuation
- 52 week high
- ₹575
- 52 week low
- ₹425
- P/B ratio
- 4.89
- Debt to equity
- 0.23
- ROE (%)
- 12.76%
- Book value
- ₹101.82
- Face value
- ₹2
- Valuation
- —
Registry
- PAN number
- AAVCS7209P
- ISIN number
- INE110V01015
- CIN
- U74120PN2015PLC156643
Figures in cr ·
Financials
| P&L Statement | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 5197.48 | 3279 | 4918 | 4956 |
| EBITDA | 556.78 | 399 | 470 | 431 |
| OPM | 10.71 | 12.17 | 9.56 | 8.7 |
| PBT | 656.99 | 241 | 319 | 261 |
| PAT | 440.14 | 184 | 230 | 183 |
| EPS | 71.98 | 15.08 | 18.85 | 13.86 |
Shareholding Pattern
Leadership
Frequently asked questions
Common questions on Sterlite Electric Limited (formerly Sterlite Power) Unlisted Shares—tap a row to read the answer.
Q.1What does Sterlite Electric actually do?
In simple terms, they build and manage the "wiring" that carries electricity across the country. Think of it as the roads and highways for power - except instead of cars, it's carrying electricity from power plants to your homes, offices, and industries.
Q.2Is it risky to invest in unlisted shares?
Yes, more so than listed shares. A few things to keep in mind:
Liquidity risk – it can take longer to find a buyer when you want to sell, unlike listed shares which you can sell instantly.
Price transparency – there's no single "market price," so you're relying on the platform/broker's quote.
Limited information – unlisted companies don't have the same disclosure requirements as listed ones, so less public data is available.
Q.3Do I pay tax on unlisted shares like I do on listed ones?
Broadly yes, but the rules differ slightly - for example, unlisted shares are treated as long-term only if held for more than 24 months (vs. 12 months for listed shares), and tax rates can vary. Since tax treatment depends on your specific situation, it's worth checking with a tax advisor or CA before you buy or sell.
Q.4How do I know the seller/platform is genuine?
Stick to well-known, established brokers or platforms with a track record in unlisted share dealing, and always insist on proper documentation (share transfer form, contract note, etc.) for every transaction - never pay informally without paperwork.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
